Back to search results

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Stage II Rectal Cancer · Organ Preservation · Non-operative Treatment · Rectal Cancer (Stage III) · Rectal Cancer Patients

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UT Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Cristian Gonzales) · Cristian.Gonzalez@UTSouthwestern.edu · 214-645-5360
    Contact: Principal Investigator (Aurelie Garant, MD)

  • Le Centre Hospitalier de l'Université de Montreal, Montreal, Quebec, Canada

    Contact: Study coordinator (Nassima Taleb) · nassima.taleb.chum@ssss.gouv.qc.ca · 514-890-8000
    Contact: Principal Investigator (Carole Richard, MD)

  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Susanne Knoepfel) · sknoepfel@jgh.mcgill.ca · 514-340-8222
    Contact: Principal Investigator (Te Vuong, MD)

  • Centre hospitalier universitaire de Québec, Québec, Quebec, Canada

    Contact: Study coordinator (André-Guy Martin, MD)
Study leads

  • Te Vuong, MD

    Principal Investigator

    Sir Mortimer Jewish General Hospital

View source on ClinicalTrials.gov(opens in a new tab)